BamSEC and AlphaSense Join Forces
Learn More

Vivus Inc

Formerly OTC: VVUSQ

Underwriting Agreements Filter

EX-1
from DFAN14A 2 pages July 17, 2013 We Are Writing to Request That You Desist in Your Practice of Making False Accusations With Respect to First Manhattan Co. (“Fmc”)
12/34/56
EX-1
from DEFA14A 3 pages Vivus Identifies False and Misleading Statements Made by First Manhattan Co. Fmc’s “Win at All Costs” Campaign Infringes on Stockholders’ Rights to Make Informed Voting Decisions Vivus Urges Stockholders to Vote for the Company’s Nominees on the Gold Proxy Card
12/34/56
EX-1
from DFAN14A 2 pages First Manhattan Continues to Seek Fair Settlement Vivus Board Continues to Disrespect the Shareholder Mandate
12/34/56
EX-1
from DFAN14A 2 pages July 17, 2013 We Are Writing to Request That You Desist in Your Practice of Making False Accusations With Respect to First Manhattan Co. (“Fmc”)
12/34/56
EX-1
from DFAN14A 2 pages First Manhattan Asks Delaware Court to Certify Results of Vivus’ Annual Meeting Seeks Declaratory and Injunctive Relief to Remedy Vivus Board Efforts to Entrench Themselves
12/34/56
EX-1
from DFAN14A 2 pages First Manhattan Calls Adjournment of Annual Meeting by the Vivus Board a Desperate Act to Disenfranchise Shareholders
12/34/56
EX-1
from DEFA14A 4 pages Vivus Reminds Stockholders to Vote the Gold Proxy Card by Telephone or Internet Today Vivus’s Board and Management Team Successfully Executing on the Right Strategy to Maximize Stockholder Value
12/34/56
EX-1
from DEFA14A 5 pages Strong Support for Vivus’s Board and Management Team Among Influential Financial Analysts Vivus’s Board and Management Team Are Executing on the Right Strategy to Maximize Stockholder Value Vivus’s Board Urges Stockholders to Vote for the Board’s Nominees on the Gold Proxy Card Today
12/34/56
EX-1
from DEFA14A 5 pages Vivus Board and Management Team Successfully Executing Plan to Unlock the Full Potential of Qsymia Stockholders Urged to Vote for the Board’s Nominees on the Gold Proxy Card Today
12/34/56
EX-1
from DFAN14A 7 pages First Manhattan Reminds Vivus Shareholders That Time Is Running Out to Save Vivus
12/34/56
EX-1
from DFAN14A 7 pages First Manhattan Reminds Vivus Shareholders That Time Is Running Out to Save Vivus
12/34/56
EX-1
from DFAN14A 4 pages Iss and Egan Jones Recommend That Vivus Stockholders Vote for First Manhattan’s Nominees for Election to Vivus Board Iss Recommends That Vivus’ Stockholders Do Not Vote Vivus’ Gold Proxy Card
12/34/56
EX-1
from DFAN14A 3 pages First Manhattan Announces That Anthony Zook Has Agreed to Serve as Vivus CEO if Its Director Nominees Are Elected Zook Brings 30 Years of Experience in Pharmaceutical Sales, Commercialization and Leadership
12/34/56
EX-1
from DFAN14A 3 pages First Manhattan Outlines Strategic Plan to Fix Vivus Plan Addresses Failed Qsymia Launch and Spiraling Expenses That Are Causing a Hemorrhaging of Cash
12/34/56
EX-1
from DFAN14A 53 pages Underwriting agreement
12/34/56
EX-1.1
from 8-K 37 pages Vivus, Inc. $220,000,000 4.50% Senior Convertible Notes Due 2020 Purchase Agreement
12/34/56
EX-1
from DFAN14A 2 pages April 24, 2013 via Electronic Mail and Fedex Hogan Lovells US Llp Columbia Square 555 Thirteenth Street, Nw Washington, D.C. 20004 Att: Joseph E. Gilligan Re: Nomination of Directors to the Board of Vivus, Inc. Dear Mr. Gilligan
12/34/56
EX-1.1
from 8-K 41 pages Vivus, Inc. 9,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages Vivus, Inc. 9,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 30 pages 6,250,000 Shares Vivus, Inc. Shares of Common Stock $0.001 Par Value Underwriting Agreement
12/34/56